Form 4 for ABBV AbbVie
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-17 · accession 0001415889-23-002947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-21 | 2023-02-17 | ABBV | AUSTIN ROXANNE S | Dir | S - Sale | $150.50 | -10.0K | 40.7K | -20% | -$1.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2023-02-17 | S | D | 10,000 | $150.50 | 40,705 | D | — | — |